| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6dc366c0aaffdd5aa173a2695239920
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28ad7c62ab078866ca536273c2880602 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2005-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc9a09a3a958c8226eba137400eea30b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57d67d1f5f40ca1c122f7513c36cf8c4 |
| publicationDate |
2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006240104-A1 |
| titleOfInvention |
Controlled or sustained-release formulation |
| abstract |
A formulation comprising: a co-polyester comprising (a) the reaction product of a polycondensation polyester and (b) glycolide; wherein the polycondensation polyester comprises the reaction product of diglycolic acid and/or a derivative thereof and ethylene glycol, and the co-polyester comprises about 40% by weight of the polycondensation polyester based on the total weight of the co-polyester; and a drug selected from the group consisting of indomethacin, diclofenac sodium, and ketoprofen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202022100544-U1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2493518-B1 |
| priorityDate |
2005-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |